Skip to content
WeighLab
Menu

Head-to-head · Cost-Efficiency Index

HelloWellness vs Mochi Health

Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.

Better valueGrade C · #324

HelloWellness

Cost-first shoppers who want price-sensitive shoppers willing to commit to a 3-month term for a low compounded GLP-1 starting price.

Visit HelloWellness
VS
Grade C · #330

Mochi Health

Shoppers who want obesity-medicine physician access bundled with the prescription, and don't mind two separate line items.

Visit Mochi Health

The verdict

Too close to callGrade C vs C

HelloWellness and Mochi Health tie on the Cost-Efficiency Index at 56/100, so neither wins outright on the numbers. For most shoppers we'd start with HelloWellness (ranked #324, a hair above #330) — Cost-first shoppers who want price-sensitive shoppers willing to commit to a 3-month term for a low compounded GLP-1 starting price. But Mochi Health is a genuine coin-flip alternative here.

Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs HelloWellness.

Factor by factor

Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.

Normalized Cost/Month

60
40

Price Transparency

78
64

Nationwide Access

24
52

Formulation Options

66
66

Clinical Oversight

77
79

Contract Flexibility

20
41

Pricing, coverage & formulary

The disclosed facts behind the scores. Lower price wins its row (teal).

SpecHelloWellnessMochi Health
Cost-Efficiency Index56/10056/100
Semaglutide / mo$133/mo (starting dose, 3-month plan, compounded)$178/mo (starting dose, plus a separate fee, compounded)
Tirzepatide / mo$166/mo (starting dose, 3-month plan, compounded)$278/mo (starting dose, plus a separate fee, compounded)
Semaglutide / yr (modeled)$1,596$2,136
Tirzepatide / yr (modeled)$1,992$3,336
CoverageCoverage not published15 states
Oral / sublingualNoNo
Brand-name accessCompounded onlyCompounded only
Rank here#324#330

HelloWellness

56/100

Where the value is

  • $133/mo semaglutide and $166/mo tirzepatide starting prices are among the lowest publicly advertised in the compounded market
  • Full refund issued if a patient isn't medically approved, stated plainly on the homepage
  • Shipments include syringes, needles, and injection instructions, not just the medication

The tradeoffs

  • 3-month minimum commitment — you're billed monthly for all 3 months even if you want to stop after month one
  • The LegitScript seal displayed on this site verifies hellowellness.ai, not the hellowellness.health domain it appears on — the certification doesn't clearly cover the site you're ordering from
Visit HelloWellness

Full HelloWellness review →

Mochi Health

56/100

Where the value is

  • Names five board-certified obesity-medicine physicians on its About page (Valledor, Jones, Barrick, A. Patel, Am. Patel MDs/DOs), unusual specificity for this tier of provider
  • Available in all 50 states per the About page, a real expansion from the network dataset's outdated '15 states'
  • Membership includes ongoing care-team messaging and coaching, not just a one-time prescription

The tradeoffs

  • The advertised '$99' and '$199' medication prices are NOT the monthly cost — a separate $79/mo membership is mandatory and stacks on top, so the real floor is $178/mo (semaglutide) and $278/mo (tirzepatide)
  • No compounding pharmacy is named anywhere on the site, including a dedicated /pharmacy page that markets the partnership program without ever identifying a partner
Visit Mochi Health

Full Mochi Health review →

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.

Keep comparing

← All head-to-head comparisons